MedPath

XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort

Phase 4
Completed
Conditions
Chronic Total Occlusion of Coronary Artery
Vascular Disease
Myocardial Ischemia
Coronary Artery Stenosis
Coronary Disease
Coronary Artery Disease
Coronary Restenosis
Interventions
Device: XIENCE V Everolimus Eluting Coronary Stent System (XIENCE V EECSS)
Registration Number
NCT01106534
Lead Sponsor
Abbott Medical Devices
Brief Summary

XIENCE V USA is a prospective, multi-center, multi-cohort postapproval study. The objectives of this study are

* To evaluate XIENCE V EECSS continued safety and effectiveness during commercial use in real world settings, and

* To support the Food and Drug Administration (FDA) dual antiplatelet therapy (DAPT) initiative. This initiative is designed to evaluate the composite of all death, myocardial infarction (MI) and stroke (MACCE) and the survival of patients that are free from Academic Research Consortium (ARC) definite or probable stent thrombosis (ST) and that have been treated with drug eluting stents (DES) and extended dual antiplatelet therapy.

Detailed Description

This prospective, multi-center, randomized, double-blind AV-DAPT study cohort is designed to collect data to support the FDA DAPT initiative. The protocol for AV-DAPT cohort is designed according to the HCRI-DAPT (NCT00977938) study protocol, Study IDE # G080186.

A total 8040 patients (5034 in initial enrollment phase and additional \~3000 patients in the second enrollment phase) enrolled in the XIENCE V USA (NCT00676520) had completed Phase I and were evaluated at 1 year.

These patients were transferred to the following cohorts in Phase II and followed-up for 1-5 years:

The long-term follow-up cohort of phase II (NCT01120379) consisted of 5020 patients from the first enrollment phase who were not transferred to the HCRI- DAPT study and remained in the study beyond 1 year.

Patients from the additional 3000 treated with the XIENCE V EECSS who are free from events (death, MI, repeat coronary revascularization, stroke, ST, or major bleeding - "severe" or "moderate" by GUSTO classification) in the first year after the index procedure, and are compliant with DAPT will be identified as prospective patients for the AV-DAPT cohort. A total of 870 Patients who are considered as part of the AV-DAPT cohort will continue with Aspirin therapy and will be randomized at 12 months post index procedure to 18 months of either active treatment with thienopyridines or placebo. Clinical follow-up will occur at 15, 24, 30 and 33 months. These patients will be followed by Abbott Vascular.

The remaining patients from the additional 3000 patients who did not participate in AV-DAPT cohort will be followed for the first year only. A study completion form will be filled out and the patients will not be followed beyond their 1 year visit.

The participants enrolled in this study will be followed by Abbott Vascular but their data will not be independently analyzed; they will only be analyzed as part of the DAPT study (NCT00977938) which is sufficiently powered for the study outcomes.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
870
Inclusion Criteria
  • Patients who are enrolled into the XIENCE V USA Study Phase I
  • The patient agrees to participate in this study by signing the Institutional Review Board (IRB) approved informed consent form. Alternatively, the patient's legally authorized representative agrees to the patient's participation in this study and signs the informed consent form.
Exclusion Criteria
  • The inability to obtain an informed consent is an exclusion criterion.

Patients must meet the following criteria to be eligible for randomization in the study:

  • Patient is "12 Month Clear": "12-Month Clear" patients are free from death, MI, stroke, repeat coronary revascularization, major bleeding - "severe" or "moderate" by GUSTO classification, and ST 12 months after stent implantation. Staged PCI is allowed (same stent type as index); repeat PCI and peri-procedural myocardial infarction occurring with the index procedure or repeat procedure within the first 6 weeks will not be considered exclusionary events for the definition of "12 Month Clear".
  • Patient is "DAPT Compliant": During the open label portion of this study (time 0-12 months), a patient is considered compliant with the thienopyridine therapy for the purposes of eligibility if they take between 80% and 120% of the prescribed drug in a given period without an interruption of therapy longer than 14 days. This information will be ascertained via data collected at the patient interviews at 6 and 12 months post-procedure. Compliance at both time points is required to be considered "clear".
  • Patient completes 1 year visit within ± 30 days window.

Patients will be excluded from randomization if any of the following criteria are met:

  • Pregnant women.
  • Switched thienopyridine type or dose within 6 months prior to randomization. Note: Thienopyridine switching during the open label portion of this study is discouraged.
  • PCI or cardiac surgery between 6 weeks post index procedure and randomization.
  • Planned surgery necessitating discontinuation of antiplatelet therapy within the 21 months following randomization.
  • Current medical condition with a life expectancy of less than 3 years.
  • Patients on warfarin or similar anticoagulant therapy.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
12 month DAPT armplacebo + aspirinplacebo + aspirin
12 month DAPT armXIENCE V Everolimus Eluting Coronary Stent System (XIENCE V EECSS)placebo + aspirin
30 month DAPT armclopidogrel + aspirin OR prasugrel + aspirinclopidogrel + aspirin OR prasugrel + aspirin
30 month DAPT armXIENCE V Everolimus Eluting Coronary Stent System (XIENCE V EECSS)clopidogrel + aspirin OR prasugrel + aspirin
Primary Outcome Measures
NameTimeMethod
Major Bleeding (GUSTO Classification, Severe and Moderate Bleeding Combined)12-33 months post-stent
Incidence of Composite of All Death, MI and Stroke (Defined as MACE)12-33 months post-stent
Incidence of ARC Definite or Probable ST12-33 months post-stent
Secondary Outcome Measures
NameTimeMethod
ST for ITT Population12 through 30 months
MACE for ITT Population12 through 30 months
Major Bleeding for ITT Population12 through 30 months
MACE for Treatment Population12 through 30 months and 12 through 33 months
ST for Treatment Population12 through 30 months and 12 through 33 months
Major Bleeding for Treatment Population12 through 30 months and 12 through 33 months

Trial Locations

Locations (144)

Piedmont Hospital

🇺🇸

Atlanta, Georgia, United States

Union Memorial Hospital

🇺🇸

Baltimore, Maryland, United States

The Care Group at Methodist

🇺🇸

Indianapolis, Indiana, United States

St. Francis Hospital and Health Centers

🇺🇸

Indianapolis, Indiana, United States

Indiana Heart Hospital

🇺🇸

Indianapolis, Indiana, United States

The Methodist Hospital

🇺🇸

Houston, Texas, United States

University of Cincinnati Medical Center

🇺🇸

Cincinnati, Ohio, United States

North Memorial Medical Center

🇺🇸

Minneapolis, Minnesota, United States

Mercy Hospital

🇺🇸

Minneapolis, Minnesota, United States

Duke University Medical Center

🇺🇸

Durham, North Carolina, United States

South Texas Methodist Hospital

🇺🇸

San Antonio, Texas, United States

St. John's Research Institute, Inc., St. John's Hospital

🇺🇸

Springfield, Missouri, United States

Carolinas Medical Center

🇺🇸

Charlotte, North Carolina, United States

Scottsdale Healthcare

🇺🇸

Scottsdale, Arizona, United States

Thomas Hospital

🇺🇸

Fairhope, Alabama, United States

Jackson Heart Clinic

🇺🇸

Jackson, Mississippi, United States

Billings Clinic Research Center

🇺🇸

Billings, Montana, United States

Morton Plant Hospital

🇺🇸

Clearwater, Florida, United States

St. Joseph's Regional Medical Center

🇺🇸

Paterson, New Jersey, United States

The Valley Hospital

🇺🇸

Ridgewood, New Jersey, United States

Mount Sinai Medical Center

🇺🇸

New York, New York, United States

Rochester Cardiopulmonary Group

🇺🇸

Rochester, New York, United States

FACT/ Los Angeles Cardiology

🇺🇸

Los Angeles, California, United States

North Kansas City Hospital

🇺🇸

North Kansas City, Missouri, United States

University of Southern California

🇺🇸

Los Angeles, California, United States

The Christ Hospital

🇺🇸

Cincinnati, Ohio, United States

The Toledo Hospital-Jobst Vascular Center

🇺🇸

Toledo, Ohio, United States

Sacred Heart Medical Center

🇺🇸

Eugene, Oregon, United States

Torrance Memorial Medical Center

🇺🇸

Torrance, California, United States

Altru Health System

🇺🇸

Grand Forks, North Dakota, United States

Saint Joseph's Hospital of Atlanta

🇺🇸

Atlanta, Georgia, United States

Fairview Hospital

🇺🇸

Fairview Park, Ohio, United States

Hillcrest Medical Center

🇺🇸

Tulsa, Oklahoma, United States

Elkhart Midwest Cardiovascular Research & Education Foundation

🇺🇸

Elkhart, Indiana, United States

Stony Brook Hospital and Medical Center

🇺🇸

Stony Brook, New York, United States

Hahnemann Hospital

🇺🇸

Philadelphia, Pennsylvania, United States

Buffalo Heart group

🇺🇸

Buffalo, New York, United States

St. Vincent Mercy Medical Center

🇺🇸

Toledo, Ohio, United States

Midwest Regional Medical Center

🇺🇸

Midwest City, Oklahoma, United States

Dartmouth Hitchock Medical Center

🇺🇸

Lebanon, New Hampshire, United States

Englewood Hospital & Medical Center

🇺🇸

Englewood, New Jersey, United States

Gaston Memorial Hospital

🇺🇸

Gastonia, North Carolina, United States

Cardiology Associates of Southeastern Ohio, Inc

🇺🇸

Zanesville, Ohio, United States

Bryn Mawr Hospital

🇺🇸

Bryn Mawr, Pennsylvania, United States

Doylestown Hospital

🇺🇸

Doylestown, Pennsylvania, United States

Virginia Cardiovascular Consultants

🇺🇸

Fredericksburg, Virginia, United States

West Clinic d/b/a Memphis Heart Clinic

🇺🇸

Memphis, Tennessee, United States

Franklin County Heart Center at Summit Cardiology

🇺🇸

Chambersburg, Pennsylvania, United States

Wisconsin Heart Hospital

🇺🇸

Wauwatosa, Wisconsin, United States

York Hospital

🇺🇸

York, Pennsylvania, United States

St Mary's Medical Hospital

🇺🇸

Huntington, West Virginia, United States

University of Virginia Health System

🇺🇸

Charlottesville, Virginia, United States

Overlake Hospital Medical Center

🇺🇸

Bellevue, Washington, United States

Main Line Health Heart Center/The Lankenau Hospital

🇺🇸

Wynnewood, Pennsylvania, United States

The Western Pennsylvania Hospital

🇺🇸

Pittsburgh, Pennsylvania, United States

Holy Spirit Hospital

🇺🇸

Wormleysburg, Pennsylvania, United States

Lubbock Heart Hospital

🇺🇸

Lubbock, Texas, United States

Carilion Roanoke Memorial

🇺🇸

Roanoke, Virginia, United States

The Miriam Hospital

🇺🇸

Providence, Rhode Island, United States

Sentara Norfolk General Hospital

🇺🇸

Norfolk, Virginia, United States

Permian Research Foundation

🇺🇸

Odessa, Texas, United States

AnMed Health

🇺🇸

Anderson, South Carolina, United States

Cotton O'Neil Clinical Research Center

🇺🇸

Topeka, Kansas, United States

Galichia Heart Hospital

🇺🇸

Wichita, Kansas, United States

Baystate Medical Center

🇺🇸

Springfield, Massachusetts, United States

St. Thomas Hospital

🇺🇸

Nashville, Tennessee, United States

Centennial Heart Cardiovascular Consultants, LLC.

🇺🇸

Nashville, Tennessee, United States

Vanderbilt Vniversity Medical Center

🇺🇸

Nashville, Tennessee, United States

Integris Baptist Medical, Inc.

🇺🇸

Oklahoma City, Oklahoma, United States

The University of Oklahoma Health Sciences Center

🇺🇸

Oklahoma City, Oklahoma, United States

St John Hospital & Medical Center

🇺🇸

Detroit, Michigan, United States

St. Vincent's Medical Center

🇺🇸

Norwalk, Connecticut, United States

Birmingham Heart Clinic, PC

🇺🇸

Birmingham, Alabama, United States

Barnes Jewish Hospital

🇺🇸

Saint Louis, Missouri, United States

The Medical Center of Aurora

🇺🇸

Aurora, Colorado, United States

Aurora St. Luke's Medical Center

🇺🇸

Milwaukee, Wisconsin, United States

Sparrow Hospital

🇺🇸

Lansing, Michigan, United States

Mid Carolina Cardiology

🇺🇸

Charlotte, North Carolina, United States

High Point Regional Health System

🇺🇸

High Point, North Carolina, United States

WakeMed Hospital

🇺🇸

Raleigh, North Carolina, United States

St. Peters Hospital

🇺🇸

Albany, New York, United States

California Cardiovascular Consultants

🇺🇸

Fremont, California, United States

Arkansas Heart Hospital

🇺🇸

Little Rock, Arkansas, United States

Salinas Valley Memorial Healthcare System

🇺🇸

Salinas, California, United States

Sansum Clinic

🇺🇸

Santa Barbara, California, United States

St. Anthony's Central Hospital

🇺🇸

Denver, Colorado, United States

Washington Hospital Center

🇺🇸

Washington, District of Columbia, United States

Brandon Regional Hospital

🇺🇸

Brandon, Florida, United States

Memorial Regional Hospital

🇺🇸

Hollywood, Florida, United States

Sacred Heart Hospital

🇺🇸

Pensacola, Florida, United States

Cardiology Partners Clinical Research Institute (Formerly Palm Beach Gardens Medical Center)

🇺🇸

Wellington, Florida, United States

University Hospital Augusta Cardiology Clinic

🇺🇸

Augusta, Georgia, United States

NE Georgia Medical Center

🇺🇸

Gainesville, Georgia, United States

WellStar Kennestone Hospital

🇺🇸

Marietta, Georgia, United States

Midwest Heart Foundation

🇺🇸

Lombard, Illinois, United States

St. John's Hospital / Prairie Education & Research Cooperative

🇺🇸

Springfield, Illinois, United States

Heart Care Midwest (OSF/St Francis)

🇺🇸

Peoria, Illinois, United States

Maine Cardiology Associates

🇺🇸

South Portland, Maine, United States

Northeast Cardiology Associates

🇺🇸

Bangor, Maine, United States

Johns Hopkins Hospital

🇺🇸

Baltimore, Maryland, United States

Peninsula Regional Medical Center

🇺🇸

Salisbury, Maryland, United States

Lahey Clinic

🇺🇸

Burlington, Massachusetts, United States

St. Joseph Medical Center

🇺🇸

Towson, Maryland, United States

UMass Memorial Medical Center

🇺🇸

Worcester, Massachusetts, United States

Boston Medical Center East

🇺🇸

Boston, Massachusetts, United States

Oakwood Hospital and Medical Center

🇺🇸

Dearborn, Michigan, United States

Michigan Cardio Vascular Institute at St. Mary's of MI

🇺🇸

Saginaw, Michigan, United States

Northern Michigan Hospital

🇺🇸

Petoskey, Michigan, United States

William Beaumont Hospital

🇺🇸

Royal Oak, Michigan, United States

St. Joseph Mercy Oakland Hospital

🇺🇸

Pontiac, Michigan, United States

Covenant Medical Center, INC.

🇺🇸

Saginaw, Michigan, United States

St. Joseph Mercy Hospital

🇺🇸

Ypsilanti, Michigan, United States

Lakeland Hospital St. Joseph

🇺🇸

Saint Joseph, Michigan, United States

St. Paul Heart Clinic

🇺🇸

Saint Paul, Minnesota, United States

Southern Heart Center

🇺🇸

Hattiesburg, Mississippi, United States

St. Joseph's Hospital Health Center

🇺🇸

Syracuse, New York, United States

Abington Memorial Hospital

🇺🇸

Abington, Pennsylvania, United States

Tri-State Medical Group

🇺🇸

Beaver, Pennsylvania, United States

Lancaster Heart & Stroke Foundation

🇺🇸

Lancaster, Pennsylvania, United States

Geisinger Medical Center

🇺🇸

Danville, Pennsylvania, United States

Penn Presbyterian Medical Center

🇺🇸

Philadelphia, Pennsylvania, United States

Providence Hospital-SC

🇺🇸

Columbia, South Carolina, United States

Amarillo Heart Clinical Research Institute

🇺🇸

Amarillo, Texas, United States

Baylor Heart and Vascular Hospital

🇺🇸

Dallas, Texas, United States

Sarasota Memorial Hospital

🇺🇸

Sarasota, Florida, United States

Intermountain Medical Center

🇺🇸

Salt Lake City, Utah, United States

Eisenhower Medical Center, Desert Cardiology Center

🇺🇸

Rancho Mirage, California, United States

North Ohio Research LTD, Elyria Regional Medical Center

🇺🇸

Elyria, Ohio, United States

Memorial Health System

🇺🇸

Chattanooga, Tennessee, United States

Providence Everett Medical Center

🇺🇸

Everett, Washington, United States

St. Joseph's Tacoma

🇺🇸

Tacoma, Washington, United States

Hackensack Medical Center

🇺🇸

Hackensack, New Jersey, United States

CADV

🇺🇸

Haddon Heights, New Jersey, United States

Regional Cardiology Associates

🇺🇸

Sacramento, California, United States

St. Luke's Hospital

🇺🇸

Kansas City, Missouri, United States

University of North Carolina

🇺🇸

Chapel Hill, North Carolina, United States

Forsyth Medical Center

🇺🇸

Winston-Salem, North Carolina, United States

Wake Forest University Baptist Medical Center

🇺🇸

Winston-Salem, North Carolina, United States

Washington Adventist Hospital

🇺🇸

Takoma Park, Maryland, United States

Jack D. Weiler Hospital of Montefiore Medical Center

🇺🇸

Bronx, New York, United States

Capital Cadiovascular Specialists

🇺🇸

Austin, Texas, United States

Central Baptist Hospital

🇺🇸

Lexington, Kentucky, United States

Sanford USD Medical Center

🇺🇸

Sioux Falls, South Dakota, United States

Harrisburg Hospital / Pinnacle Health

🇺🇸

Harrisburg, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath